Celgene Corp. buy melinda
Start price
28.08.10
/
50%
€20.35
Target price
28.02.11
€25.00
Performance (%)
-4.90%
End price
28.02.11
€19.35
Summary
This prediction ended on 28.02.11 with a price of €19.35. With a performance of -4.90%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% | 60.023% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% | 85.321% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% | 61.038% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% | 57.738% |
Comments by melinda for this prediction
In the thread Celgene Corp. diskutieren
biopharmazeutisches
Celgene und filialles Biopharma Unternehmen in der Discovery-Prozess, Krebs und entzündliche Erkrankungen des Immunsystems beteiligt
(Laufzeit überschritten)